Latest News

Daily Recap: Docs are good at saving money; SARS-CoV-2 vaccine trials advance


 

Could a visual tool aid migraine management?

A new visual tool aims to streamline patient-clinician communication about risk factors for progression from episodic to chronic migraines.

The tool is still just a prototype, but it could eventually synthesize patient responses to an integrated questionnaire and produce a chart illustrating where the patient stands with respect to a range of modifiable risk factors from depression to insomnia.

Physicians must see patients in short appointment periods, making it difficult to communicate all of the risk factors and behavioral characteristics that can contribute to risk of progression. “If you have a patient and you’re able to look at a visualization tool quickly and say: ‘Okay, my patient really is having insomnia and sleep issues,’ you can focus the session talking about sleep, cognitive-behavioral therapy for insomnia, and all the things we can help patients with,” lead researcher Ami Cuneo, MD, who is a headache fellow at the University of Washington, Seattle, said in an interview.

Dr. Cuneo presented a poster describing the concept at the virtual annual meeting of the American Headache Society. Read more.

For more on COVID-19, visit our Resource Center. All of our latest news is available on MDedge.com.

Pages

Recommended Reading

First reported U.S. case of COVID-19 linked to Guillain-Barré syndrome
MDedge Endocrinology
COVID-associated pancreatitis may disproportionately affect young, overweight men
MDedge Endocrinology
Daily Recap: Healthy lifestyle may stave off dementia; Tentative evidence on marijuana for migraine
MDedge Endocrinology
Daily Recap: COVID-19 care delays mean excess cancer deaths; flu vaccine recommendations
MDedge Endocrinology
Daily Recap: Higher risk of severe COVID-19 seen in pregnancy, primary care practices at risk
MDedge Endocrinology
ACIP plans priority groups in advance of COVID-19 vaccine
MDedge Endocrinology
How racism contributes to the effects of SARS-CoV-2
MDedge Endocrinology
Daily Recap: Transgender patients turn to DIY treatments; ACIP plans priority vaccine groups
MDedge Endocrinology
Skin patterns of COVID-19 vary widely
MDedge Endocrinology
Phase 3 COVID-19 vaccine trials launching in July, expert says
MDedge Endocrinology